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No Association of Functional Polymorphisms in 
Methlylenetetrahydrofolate Reductase and the Risk and Minor 
Physical Anomalies of Schizophrenia in Korean Population
Methylenetetrahydrofolate reductase (MTHFR), a critical enzyme in folate metabolism, 
plays an important role in DNA methylation. It has been suggested that abnormal DNA 
methylation contributes to the pathogenesis of schizophrenia and congenital anomalies. 
The previous findings regarding the genetic relationship between MTHFR and schizophrenia 
are controversial. This study investigated the association of the two functional 
polymorphisms of MTHFR, C677T and A1298C, with the risk for schizophrenia. 
Furthermore, we conducted an updated meta-analysis on the two polymorphisms. In 
addition, we investigated the relationship between the polymorphisms and minor physical 
anomaly (MPA), which may represent neurodevelopmental aberrations in 201 
schizophrenia patients and 350 normal control subjects. There was no significant 
association between either of the two polymorphisms and the risk of schizophrenia (chi-
square = 0.001, df = 1, P = 0.971 for C677T; chi-square = 1.319, df = 1, P = 0.251 for 
A1298C). However, in meta-analysis, the C677T polymorphism showed a significant 
association in the combined and Asian populations (OR = 1.13, P = 0.005; OR = 1.21, 
P = 0.011, respectively) but not in the Korean and Caucasian populations alone. Neither 
polymorphism was associated with MPAs measured by the Waldrop scale (chi-square =  
2.513, df = 2, P = 0.285). In conclusion, the present findings suggest that in the Korean 
population, the MTHFR polymorphisms are unlikely to be associated with the risk for 
schizophrenia and neurodevelopmental abnormalities related to schizophrenia. 
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INTRODUCTION
Methylenetetrahydrofolate reductase (MTHFR) is an enzyme 
that reduces 10-methylenetetrahydrofolate (10-MTHF) to 5-meth-
ylenetetrahydrofolate (5-MTHF). 5-MTHF is a cofactor for the 
remethylation of homocysteine to convert it to S-adenosyl me-
thionine, which is methyl group donor for DNA methyltransfer-
ases (1). It has long been suggested that abnormal methylation 
contributes to the pathogenesis of schizophrenia through down-
stream methylation-dependent processes (2) and through the 
alteration of neurotransmitters, including dopamine, serotonin, 
GABA, etc. (3).
  In addition, it has been suggested that MTHFR is related to 
the pathophysiology of abnormal congenital development. Folic 
acid supplementation during early pregnancy reduces some con-
genital anomalies, such as neural tube defects, oro-facial clefts 
and heart defects (4). Although the exact mechanism of how fo-
lic acid metabolism affects fetal development is not known, sev-
eral genetic studies on the association between folate metabo-
lism and congenial anomalies have been carried out (5, 6). As 
an influential enzyme in folate metabolism, the MTHFR gene is 
one of the candidates that have been studied. Several congeni-Kim S-G, et al.  •  MTHFR Gene Polymorphisms and Minor Physical Anomalies in Schizophrenia
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tal central nervous system anomalies, such as neural tube de-
fects, have been reported to be related to MTHFR gene polymor-
phisms (5, 6).
  Patients with schizophrenia have been reported to have high-
er incidence of minor physical anomalies (MPAs) than control 
groups (7). MPAs are minor abnormalities of morphogenesis 
that lead to subtle alterations in the development of various bodi-
ly structures in the area of the face, eyes, ears, mouth, and feet. 
The presence of MPAs in patients with schizophrenia has been 
reported as a stable manifestation (7, 8) and it has been suggest-
ed that they reflect the genetic vulnerability for schizophrenia 
(8, 9). MPAs also meet the criteria of endophenotype in schizo-
phrenia (8). Although their direct relationship with psychiatric 
symptoms has not been established, from a developmental per-
spective both the external tissues and the central nervous sys-
tem share a common ectoderm origin. Therefore, MPAs seen in 
schizophrenic patients may have a common genetic background 
with neural tube defects, which are related to MTHFR polymor-
phisms. Accordingly, MTHFR is a good candidate marker to ex-
plain the relationship between schizophrenia and MPAs.  
  Two common single nucleotide polymorphisms in MTHFR 
gene have been reported. One is a C/T transition at nucleotide 
677 in exon 4, and the other is an A/C transversion in exon 7 at 
position 1298. Both mutations are functional and result in a re-
duction in the enzyme’s activity (10). The association of MTHFR 
gene polymorphisms at C677T and A1298C with schizophrenia 
has been studied in various populations. Some studies have re-
ported an association of the single nucleotide polymorphisms 
(SNPs) with schizophrenia (11-18), but others have reported no 
association (19-27). Several meta-analyses continue to indicate 
the positive association of the C677T polymorphism with schizo-
phrenia (1, 19, 28-30). The positive association between the C677T 
polymorphism and schizophrenia was suggested to occur mainly 
in East Asians (1, 16), which suggests a higher risk for schizophre-
nia from the MTHFR gene in Asian populations. In the Korean 
population, Lee et al. (16) reported a positive association of the 
C677T polymorphism and schizophrenia. However, Kang et al. 
(20) recently reported no association with the C677T polymor-
phism. Therefore, further investigation is needed into the rela-
tionship between the MTHFR polymorphism and schizophre-
nia in the Korean population.
  In this study, we first examined the association of the genotype 
and the allelic frequencies of the MTHFR 677C > T and 1298 A >  
C polymorphisms with the risk for schizophrenia in the Korean 
population. Then we performed an updated meta-analysis on 
the two polymorphisms in Korean, Asian, and Caucasian popu-
lations as well as the three populations combined. Finally, we ex-
amined whether the genotypic frequencies of the MTHFR 677C >  
T and 1298 A > C polymorphisms were associated with the scores 
from the Waldrop scale, which was developed to measure MPAs 
(9, 31).
MATERIALS AND METHODS
Subjects and procedures
All patients with schizophrenia were recruited from the Seoul 
National University Hospital in Korea between March 2005 and 
September 2010. All patients fulfilled the diagnostic criteria from 
the DSM-IV for schizophrenia and were interviewed individu-
ally by trained nurses using a Korean-translated version of the 
Diagnostic Interview for Genetic Studies (DIGS) (32). Consen-
sus diagnostic meetings were held regularly to evaluate the par-
ticipants’ final diagnosis. The interview material from the DIGS 
and the hospital records were the major sources used to re-eval-
uate the diagnoses. The subjects who had a history of having any 
kind of organic abnormality of the brain, alcohol-related men-
tal problem, drug abuse, or other physical illnesses that poten-
tially manifested as psychiatric symptoms were not included in 
this study. The subjects included in the final analysis included 
201 patients (average age = 32.89 ± 7.76 yr), 133 males (average 
age = 31.75 ± 6.91 yr) and 68 females (average age = 35.10 ±  
8.85 yr). 
  Normal controls without psychiatric disorders were random-
ly recruited from hospital staff members and college students 
who volunteered for participation. After a brief interview by a 
psychiatrist, the subjects with a past history or current evidence 
of psychiatric illness, organic mental disorders, the abuse of ille-
gal substances and any medical conditions that might give rise 
to mental symptoms were excluded. In addition, control sub-
jects who had any 1st degree relatives with suspected psychiat-
ric illness were also excluded. The total number of control sub-
jects was 350 (average age = 25.9 ± 6.56 yr), 174 males (average 
age = 23.38 ± 5.51 yr) and 176 females (average age = 24.58 ±  
8.27 yr). The mean (S.D.) age of the patients with schizophrenia 
was older than that of the controls. All of the subjects with schizo-
phrenia and the control subjects were ethnically Korean.
Evaluation of minor physical anomalies
As described in Joo et al. (9), MPAs were measured with a mod-
ified 15-item Waldrop scale for both the patients with schizo-
phrenia and the normal controls. While the original 18-item Wal-
drop scale was developed to measure MPAs around the head, 
eyes, ears, mouth, hands, and feet (31), we used a modified 15-
item Waldrop scale that excluded three items (two or more hair 
whorls, soft and pliable ears, and a tongue with smooth-rough 
spots) that do not contribute to the total score (33). Our previ-
ous study showed good inter-rater reliability for the total Wal-
drop score (intraclass correlation coefficient = 0.59) (33). The 
MPAs were measured by trained researchers who could not be 
kept blind with regard to the diagnostic group membership. Pa-
tients with total Waldrop scores above 5 were defined as the high 
MPA subgroup (9). The data for the Waldrop total was present 
in 217 of 350 control group members and 122 of 201 patients. Kim S-G, et al.  •  MTHFR Gene Polymorphisms and Minor Physical Anomalies in Schizophrenia
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Genotyping
DNA was extracted from blood samples using a DNA isolation 
kit (Roche, Basel, Switzerland). Genotyping for the MTHFR C677T 
and A1298C polymorphisms was performed using the TaqMan
TM 
method (Applied Biosystems). The primer and probe sets were 
provided by Applied Biosystems (Foster City, CA, USA). The Taq-
Man probes contain a reporter dye at the 5’ end and a quencher 
dye at the 3’ end. The quencher dye suppresses the fluorescent 
signal of the reporter dye. When the probe is hybridized to the 
target sequence, Taq polymerase, which has a 5’→3’ exonucle-
ase activity, cleaves the reporter dye-labeled probes. The fluo-
rescence intensity increases as the amount of freed reporter dye 
increases. The intensity of the fluorescence was measured us-
ing an Applied Biosystems PRISM 7900HT Sequence Detector 
System. The genotypes were analyzed according to the fluores-
cence characteristics. The PCR reactions were performed in a 
5-μL total volume, which included 1 μL (50 ng) of genomic DNA, 
0.1 μL (5 pM/μL) of each probe, 0.15 μL (20 pM/μL) of each prim-
er, 2.5 μL of 2 ×  Taqman PCR Master Mix, and 1 μL of DW. The 
thermal conditions were 15 min at 95°C, 40 cycles of 15 sec at 
95°C and 60 sec at 60°C, followed by cooling to 4°C. The data anal-
ysis was done using SDS 2.1 software (Applied Biosystems), and 
these genotyping procedures were done by Seoul Clinical Ge-
nomics, Inc.
Statistical analysis
Hardy-Weinberg equilibrium was tested by a goodness of fit chi-
squared test. Contingency chi-squared tests were performed to 
compare the allele and genotype frequencies between the pa-
tients and the normal controls. Logistic regression analysis was 
performed to estimate the relative risk of the presence of high 
MPA in relation to SNP genotype using diagnosis and sex as co-
variates. Haplotype analysis for the phenotype of the affection 
status and the Waldrop total score and the linkage disequilibri-
um (LD) calculation between the C677T and A1298C SNPs were 
done using the software, UNPHASED 3.0.13 (http://www.mrc-
bsu.cam.ac.uk/personal/frank/software/unphased/). 
Ethics statement
Before beginning the study, the protocol was reviewed and ap-
proved by the institutional review board (IRB) of the Seoul Na-
tional University Hospital (IRB No. H-0106-080-002). Informed 
consent was confirmed by the IRB. All participants who signed 
written informed consent forms were provided with detailed 
information about the genetic study.
Meta-analysis 
We performed an updated meta-analysis for the C677T and 
A1298C MTHFR SNPs. For C677T, we included 3 Korean (includ-
ing this study), 5 Asian (non-Korean), and 14 Caucasian data sets 
from currently available published data to explore the difference 
among the ethnic groups (11-13, 15-27, 34-36). For A1298C, 3 
Korean (including this study), 2 Asian (non-Korean), and 9 Cau-
casian studies were included (14, 16-20, 25, 27, 35, 36).
  The homogeneity of the included studies was assessed by Co-
chrane’s Q test and the I
2 index. The Q statistics suggested that 
there was significant heterogeneity for C677T (Q = 46.85, P =  
0.001) but not for A1298C (Q = 20.57, P = 0.082). The I2 index 
also suggested moderate heterogeneity for C677T (I
2 = 0.552) 
and weak heterogeneity for A1298C (I
2 = 0.368). However, we 
decided to apply a random-effects model to both C677T and 
A1298C because the random-effects model is more widely used 
in genetic association studies and is considered more reasonable 
than a fixed-effects approach (37). The pooled estimates of the 
Odds Ratio (OR) were calculated using the DerSimonian-Laird 
method (38).
  The pooled OR was obtained for all of the included studies, 
and the subgroup ORs were obtained for each of the different 
ethnic groups (Caucasian, Asian and Korean). The significance 
of the overall Odds Ratio (OR) was determined using the Z-test. 
The threshold for statistical significance was set at P < 0.05. The 
whole analysis was done using MetaAnalyst, a freely available 
software package that is developed and maintained by Tufts 
Medical Center (39).
RESULTS
Neither the patients with schizophrenia nor the normal controls 
were found to deviate from Hardy-Weinberg equilibrium with 
regard to C677T (P = 0.962 for schizophrenics; P = 0.832 for con-
trols) and A1298C (P = 0.557 for schizophrenics; P = 0.224 for 
controls). 
Allele and Genotype frequency 
No significant association was found in the comparison of the 
patients with schizophrenia and the controls with regard to the 
allele frequency for both the C677T and the A1298C polymor-
phisms (chi-square = 0.001, df = 1, P = 0.971; chi-square = 1.319, 
df = 1, P = 0.251, respectively; Table 1). The genotype frequen-
cies for the patients with schizophrenia were similar to those of 
the normal controls, resulting in no significant association (chi-
square = 0.345, df = 2, P = 0.841; chi-square = 1.611, df = 2, P =  
0.447, respectively; Table 1). No significant association for the 
allele and the genotype frequency was found in the comparisons 
between males and females (Table 1). 
Haplotype analysis and linkage disequilibrium
According to the reference sequence information on SNPs from 
the National Center for Biotechnology Information (NCBI), the 
two SNPs are about 1900 bps apart (C677T: rs1801133, 11778965 
and A1298C: rs1801131, 11777063). The linkage disequilibrium 
was calculated as r
2 = 0.16 and D’ = 1 for the combined subjects. Kim S-G, et al.  •  MTHFR Gene Polymorphisms and Minor Physical Anomalies in Schizophrenia
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The haplotype of the C677T and A1298C polymorphism was 
not found to have a significant difference for the affection status 
between the schizophrenia and control subjects (chi-square =  
1.531, df = 2, P = 0.465). There was no haplotypic association 
for the Waldrop total score (chi-square = 0.758, df = 2, P = 0.685), 
either. 
Meta-analysis 
Meta-analysis using the combined data from the Korean, Asian, 
and Caucasian populations showed a significant association 
between the C677T SNP and the risk for schizophrenia (OR =  
Table 1. The MTHFR C677T and A1298C allele frequencies in patients with schizophrenia and control subjects
SNP   Allele frequency (%) Genotype frequency (%)
C677T  Number C T P value C/C C/T T/T P value
   Control 
   Schizophrenia 
Total
Male
Female
Total
Male
Female
350
174
176
201
133
68
391 (55.9)
195 (56.0)
196 (55.7)
225 (56.0)
147 (55.3)
  78 (57.4)
309 (44.1)
153 (44.0)
156 (44.3)
177 (44.0)
119 (44.7)
  58 (42.6)
0.971
0.849
0.739
112 (32.0)
  55 (31.6)
  57 (32.4)
    62 (30.85)
  40 (30.1)
  22 (32.4)
  167 (47.71)
  85 (48.9)
  82 (46.6)
  101 (50.25)
  67 (50.4)
  34 (50.0)
  71 (20.29)
34 (19.5)
37 (21.0)
38 (18.9)
26 (19.5)
12 (17.6)
0.841
0.955
0.819
A1298C  Number A C P value A/A A/C C/C P value
   Control 
 
   Schizophrenia
 
 
Total
Male
Female
Total
Male
Female
350 
174 
176 
201
133
  68
585 (83.6)
286 (82.2)
299 (84.9)
325 (80.9)
214 (80.5)
111 (81.6)
115 (16.4)
  62 (17.8)
  53 (15.1)
  77 (19.2)
  52 (19.5)
  25 (18.4)
 
 
 
0.251
0.584
0.369
240 (68.6)
115 (66.1)
125 (71.0)
129 (64.2)
  85 (63.9)
  44 (64.7)
105 (30.0)
  56 (32.2)
  49 (27.8)
  67 (33.3)
  44 (33.1)
  23 (33.8)
5 (1.4)
3 (1.7)
2 (1.1)
5 (2.5)
4 (3.0)
1 (1.5)
 
 
 
0.447
0.734
0.631
Contingency chi-squared tests were performed to compare the allele and genotype frequencies between the patients and the normal controls. If less than 5 cases were pres-
ent, Fisher’s exact chi-squared test was applied to test for an association.
Table 2. Case-control association analysis of the C677T MTHFR polymorphism in 
each of the populations and the meta-analysis
Study Year
Minor allele  
frequency OR 
(95% CI)
P value
Schizo-
phrenia
Control
Korean
   Lee et al. (16)
   Kang et al. (20)
   This study
   Pooled
 
2006
2010
 
0.413
0.408
0.440
 
0.334
0.399
0.441
 
1.40 (1.08-1.83)
1.04 (0.84-1.28)
1.00 (0.78-1.27)
1.12 (0.92-1.37)
 
 
 
 
0.212
Asian
   Arinami et al. (11)
   Kunugi et al. (21)
   Tan et al. (24)
   Yu et al. (27)
   Feng et al. (12)
   Pooled*
   Pooled
†
 
1997
1998
2004
2004
2009
 
 
 
0.444
0.402
0.246
0.315
0.589
 
 
 
0.377
0.382
0.196
0.306
0.411
 
 
 
1.32 (1.07-1.64)
1.09 (0.86-1.38)
1.34 (0.91-1.96)
1.04 (0.86-1.26)
2.06 (1.44-2.95)
1.29 (1.05-1.58)
1.21(1.05-1.40)
 
 
 
 
 
 
0.023
0.011
Caucasian
   Virgos et al. (26)
   Joober et al. (13)
   Sazci et al. (17)
   Yu et al. (27)
   Muntjewerff et al. (34)
   Sazci et al. (35)
   Vilella et al. (25)
   Kempisty et al. (15)
   Philibert et al. (23)
   Jonsson et al. 
      (Denamrk) (19)
   Jonsson et al. 
      (Norway) (19)
   Jonsson et al. 
      (Sweden) (19)
   Betcheva et al. (36)
   Muntjewerff et al. (22)
   Pooled
  
1999
2000
2003
2004
2005
2005
2005
2006
2006
2008
2008
2008
2009
2011
  
0.381
0.467
0.358
0.396
0.341
0.322
0.396
0.265
0.279
0.316
0.318
0.262
0.359
0.333
 
0.399
0.344
0.303
0.410
0.287
0.299
0.402
0.168
0.319
0.308
0.336
0.275
0.329
0.323
 
0.93 (0.71-1.22)
1.67 (1.11-2.51)
1.28 (0.93-1.77)
0.94 (0.73-1.22)
1.28 (1.01-1.62)
1.11 (0.88-1.41)
 0.98 (0.73-1..31)
1.78 (1.31-2.43)
0.83 (0.63-1.08)
1.04 (0.87-1.23)
0.92 (0.66-1.30)
0.94 (0.71-1.23)
1.15 (0.85-1.55)
1.05 (0.90-1.20)
1.09 (0.98-1.20)
  
 
 
 
 
 
 
 
 
 
 
 
 
 
0.106
Total
   Pooled
 
 
 
 
 
 
 
1.13 (1.04-1.23)
 
0.005
*excluding Korean data; 
†including Korean data. OR, odds ratio; CI, confidence interval.
Table 3. Case-control association analysis of the A1298C MTHFR polymorphism in 
each of the populations and the meta-analysis
Study Year
Minor allele frequency
OR 
(95% CI)
P value Schizo-
phrenia
Control
Korean
   Lee et al. (16)
   Kang et al. (20)
   This study
   Pooled
 
2006
2010
 
 
 
0.180851
0.165278
0.191542
 
 
0.222458
0.16954
0.164286
 
 
0.77 (0.61-1.06)
0.97 (0.73-1.28)
1.21 (0.88-1.66)
0.97 (0.76-1.23)
 
 
 
 
0.384
Asian
   Yu et al. (27)
   Zhang et al. (18)
   Pooled*
   Pooled
†
 
2004
2010
 
 
 
0.265217
0.225594
 
 
 
0.2251
0.173684
 
 
 
1.24 (0.93-1.67)
1.39 (1.08-1.79)
1.32 (1.09-1.60)
1.10 (0.90-1.35)
 
 
 
0.007
0.258
Caucasian
   Sazci et al. (17)
   Yu et al. (27)
   Sazci et al. (35)
   Viella et al. (25)
   Kempisty et al. (14)
   Jonsson et al. 
      (Denamrk) (19)
   Jonsson et al. 
      (Norway) (19)
   Jonsson et al. 
      (Sweden) (19)
   Betcheva et al. (36)
   Pooled
 
2003
2004
2005
2005
2007
2008
2008
2008
2009
 
 
0.334615
0.339202
0.345118
0.303797
0.27
0.338501
0.291667
0.356223
0.301075
 
 
0.289823
0.318471
0.306452
0.262821
0.208333
0.331175
0.313559
0.363481
0.351351
 
 
1.23 (0.89-1.71)
1.10 (0.91-1.32)
1.19 (0.94-1.51)
1.22 (0.89-1.68)
1.41 (1.05-1.89)
1.03 (0.87-1.23)
0.90 (0.64-1.28)
0.97 (0.75-1.25)
0.80 (0.59-1.08)
1.08 (0.98-1.19)
 
0.124
Total
   Pooled
 
 
 
 
 
 
 
1.09 (1.00-1.19)
 
0.071
*excluding Korean data; 
†including Korean data. OR, odds ratio; CI, confidence interval.Kim S-G, et al.  •  MTHFR Gene Polymorphisms and Minor Physical Anomalies in Schizophrenia
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1.13, P = 0.005; Table 2). However, when we meta-analyzed the 
three populations separately, only the Asian population showed 
a significant association (OR = 1.21, P = 0.011 for Asians, includ-
ing Korean; OR = 1.29, P = 0.023 for Asians, excluding Korean). 
No significant association was obtained for the Korean and Cau-
casian populations, (OR = 1.12, P = 0.212 for Koreans; OR = 1.09, 
P = 0.106 for Caucasians). For the A1298C polymorphism, me-
ta-analysis using the combined populations showed no associ-
ation between the polymorphism and schizophrenia (OR = 1.09, 
P = 0.071; Table 3). When we meta-analyzed the three popula-
tions separately, none of the populations showed a significant 
association (OR = 0.97, P = 0.384 for Koreans; OR = 1.10, P = 0.258 
for Asians, including Korean; OR = 1.08, P = 0.124 for Cauca-
sians) except for the Asian, excluding Koreans, population (OR =  
1.32, P = 0.007). 
Minor physical anomalies
The total Waldrop score was significantly higher in the patients 
with schizophrenia than in the normal controls (4.70 ± 1.85 for 
schizophrenia, 4.12 ± 1.57 for control, P = 0.009). The difference 
was significant only in females (4.78 ± 2.04 for schizophrenia, 
3.75 ± 1.63 for control, P = 0.007) when we analyzed data sepa-
rately for males and females. 142 out of 339 subjects was classi-
fied as a high MPA subgroup (the Waldrop total score  ≥ 5). The 
calculated odds ratios (ORs) for the presence of high MPAs asso-
ciated with the genotypes of C677T and A1298C polymorphisms 
are presented in Table 4. There was no statistically significant 
association between the Waldrop score and C677T and A1298C 
polymorphisms in relation to schizophrenia risk and sex. 
DISCUSSION
In this study, we tested the hypothesis that the MTHFR C677T 
and A1298C polymorphisms are associated with the risk of 
schizophrenia and MPA manifestations in schizophrenia. Our 
findings suggest that there is no association of the two function-
al polymorphisms with schizophrenia development. The MPAs 
also showed no association with both polymorphisms.
  The previous findings on the genetic relationship between 
MTHFR and schizophrenia have been controversial. Although 
our study showed no association between the C677T and A1298C 
SNPs and the development of schizophrenia, our meta-analysis 
demonstrated support for the association of C677T with schizo-
phrenia. Previous studies suggested that demographic differ-
ences, such as ethnicity, may influence the association of the 
MTHFR polymorphisms with psychiatric disorders (1, 35). We 
meta-analyzed the previous case-control studies for C677T by 
ethnic groups. Although we obtained no association between the 
C677T polymorphism and schizophrenia in either of the Korean 
or Caucasian populations, the Asian population showed a signif-
icant association. Taken together, ethnicity may influence the 
effect of MTHFR genetic variations on the risk of developing 
schizophrenia, although Peerbooms et al. (40) reported no sig-
nificant moderating effect of ethnicity on major psychiatric dis-
orders, including schizophrenia, bipolar disorder, and major 
depressive disorder, in their meta-analysis. For A1298C, although 
some studies reported a positive association with schizophre-
nia that was of borderline significance (1, 19, 28), more recent 
meta-analyses have indicated no association of A1298C with 
schizophrenia (29, 30). Our meta-analysis confirmed that there 
is no association between the A1298C polymorphism and schizo-
phrenia, and the results from the meta-analyses by ethnic groups 
were also consistent with the main findings. 
  The polymorphism, C677T, substitutes an alanine for a valine, 
and each copy of the variant reduces the folate-related meta-
bolic activity by approximately 35% (41). The serum homocys-
teine level is also increased by up to 25% with the TT genotype 
(42). The A1298C polymorphism causes a glutamine to be sub-
stituted for an alanine and decreases the enzyme activity to a 
lesser extent than the C677T allele (10). Therefore, MTHFR poly-
morphisms can increase serum homocysteine level and as a 
consequence result in an impairment of DNA methylation. Both 
of these are known to be risk factors for neuropsychiatric disor-
der including schizophrenia (43). In a previous study, 45% of 
schizophrenic patients with hyperhomocysteinemia were re-
ported to have inherent methylation deficiencies (44). There-
fore, the MTHFR gene polymorphisms may be related to devel-
opmental abnormalities in schizophrenia through mechanisms 
related to hyperhomocysteinemia and DNA methylation impair-
ment (43). In an animal model, both heterozygous and homo-
Table 4. Association between the Waldrop score and the genotypes of C677T and A1298C polymorphism at the MTHFR gene
SNP Genotype Number
Low MPA
N (%)
High MPA
N (%)
OR 95% CI P value
C677T
 
 
CC
CT
TT
111
162
  66
  69 (35.0)
  94 (47.7)
  34 (17.3)
42 (29.6)
68 (47.9)
32 (22.5)
1
1.145
1.577
-
0.695-1.888
0.845-2.941
-
0.595
0.152
A1298C
 
 
AA
AC
CC
225
105
    9
129 (65.5)
  63 (32.0)
  5 (2.5)
96 (67.6)
42 (29.6)
4 (2.8)
1
0.841
0.949
 
0.521-1.358
0.243-3.704
0.480
0.949
Logistic regression analysis was applied to test for an association between the Waldrop score and the C677T and A1298C polymorphism. Waldrop total scores were measured 
by the Waldrop scale that was developed to measure minor physical anomalies (9). Patients with Waldrop total score  < 5 were defined as the low MPA subgroup, and those 
≥ 5 were defined as the high MPA subgroup. OR, odds ratio; CI, confidence interval; MPA, minor physical anomaly.Kim S-G, et al.  •  MTHFR Gene Polymorphisms and Minor Physical Anomalies in Schizophrenia
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zygous MTHFR knockout mice showed decreased DNA methyl-
ation in the brain (45). Furthermore, the presence of the MTHFR 
T allele in the fetus could affect the levels of methylenetetrahy-
drofolate in circulation, which is involved in the DNA repair ca-
pacity and protecting against congenital anomalies, i.e., against 
clubfoot (46). Overall, these findings suggest that neurodevelop-
mental abnormalities in schizophrenia could be related to ab-
errant DNA methylation due to a polymorphism at the MTHFR 
gene. Developmental defects manifested as MPAs in schizo-
phrenic patients may have a common genetic cause with the 
neurodevelopmental etiology of schizophrenia, and MTHFR 
gene polymorphisms could be a crucial candidate for both of 
them. Nevertheless, our findings do not support a contribution 
of the MTHFR gene to the manifestation of MPAs and the de-
velopment of schizophrenia. As far as we know, our study is the 
only one that has reported the genetic relationship between 
MTHFR gene variants and MPAs. Because the sample size of 
the present study is small and there may be other MTHFR poly-
morphisms that are associated with schizophrenia and devel-
opmental anomalies, further studies are still called for with this 
gene. 
  The limitation of the present study is that the sample size in-
volved is relatively small. In particular, the number of CC carriers 
of the A1298C variant was too small. Studies with a larger sam-
ple size are warranted to confirm that the A1298C polymorphism 
is a risk factor for schizophrenia. In addition, although we tried 
to match the age and sex between the schizophrenia and con-
trol groups to avoid population stratification, the mean age of 
the control group was younger than that of the schizophrenic 
group. The mean age of the control group is under the age of risk 
for the development of schizophrenia. This means that the con-
trols still have a chance of developing schizophrenia in the fu-
ture. However, the lifetime prevalence of schizophrenia is only 
1% in the general population. Therefore, this should not signifi-
cantly influence our results.
  In conclusion, the present study provides evidence that the 
MTHFR C677T and A1298C variants may not influence the risk 
of schizophrenia development in the Korean population. How-
ever, meta-analyses support an association between the C677T 
variant and schizophrenia, especially in Asian populations. Fur-
thermore, the two polymorphisms may not be associated with 
the minor physical anomalies in schizophrenia, which have been 
suggested to be related to the neurodevelopmental etiology of 
schizophrenia. Additional genetic investigation is needed to fur-
ther analyze this connection.
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No Association of Functional Polymorphisms in Methlylenetetrahydrofolate 
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We investigated genetic relationship between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and the risk and 
minor physical anomalies in schizophrenia in the Korean population. We found no association between the C677T and A1298C 
polymorphisms and schizophrenia. However, an updated meta-analysis of the previous reports showed association between the 
C677T polymorphism and schizophrenia, especially in Asian population. Neither polymorphism was associated with the presence 
of minor physical anomalies that may represent neurodevelopmental aberration in schizophrenia. Taken together, our findings 
suggest that the MTHFR polymorphisms are unlikely to contribute to the risk for schizophrenia in the Korean population.